| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H22F3N5O8 |
| Molecular Weight | 541.434 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](C1=NC=NC(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)=C1F)[C@](O)(CN3C=NC=N3)C4=CC=C(F)C=C4F
InChI
InChIKey=WFVJBHINOFLFCT-XJBLVREDSA-N
InChI=1S/C22H22F3N5O8/c1-9(22(36,5-30-8-26-6-29-30)11-3-2-10(23)4-12(11)24)14-13(25)19(28-7-27-14)38-21-17(33)15(31)16(32)18(37-21)20(34)35/h2-4,6-9,15-18,21,31-33,36H,5H2,1H3,(H,34,35)/t9-,15-,16-,17+,18-,21-,22+/m0/s1
| Molecular Formula | C22H22F3N5O8 |
| Molecular Weight | 541.434 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
|
|
PARENT -> METABOLITE |
16% metabolitic product resulting from CYP450 metabolism of voriconazole.
|
Showing 1 to 1 of 1 entries